Information Library
Results for: High-quality studies - Market Access
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Forms New Biomarker Research and Development Company
Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.
-
Shifting Sands
Media Coverage — September 2, 2011
As the pressure to improve the productivity of clinical development programmes mounts on pharmaceutical companies, the current landscape for locating cost-effective clinical trials continues to evolve. One region attracting attention is the Middle East and North Africa. -
Malaria Prevention in Sub-Saharan Africa
Case Study — June 24, 2011
This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands -
Advancing Oncology Care Through Innovative Treatment Approaches
White Paper — September 22, 2010
In this new white paper, Quintiles’ oncology experts Harish Dave and Eric Groves summarize the new findings and promising results presented at the June ASCO 2010 meeting. -
NHS Motivating Patients
Case Study — May 7, 2010
In 2008, the NHS announced plans to offer free health checks for heart disease, stroke, diabetes and kidney disease. Learn why Quintiles was the right ally for the NHS to successfully launch this cardio risk assessment program. -
Patient Management
Brochure — September 25, 2009
Knowing how patients are responding to your drug in everyday life can unlock your brand’s market potential. From outcomes to proof of efficacy, real-world patient data can help support market access, payer reimbursement and — most important — help prescribers improve patient treatment and adherence. Through an exclusive partnership with Apollo Medical Systems, Innovex UK has developed a patient management data service that reports the real impact of your brand in the context of total patient management, quickly and cost-effectively. -
Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.
Presentation — June 24, 2009
Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.” -
James C. Kirk
Hear from the Experts — March 25, 2009
Jim joined Eidetics in 1988 from senior management positions in consumer and industrial product marketing, strategy, and development positions at Ocean Spray Cranberries and Gillette Company. Previously at Ocean Spray, Jim successfully spearheaded the company’s new Ingredient Division. -
Matthew Eberhart
Hear from the Experts — March 25, 2009
Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe. -
Jay Norman
Hear from the Experts — March 24, 2009
President – Quintiles Consulting Jay brings 25 years of experience in the consulting industry and a strong track record of growth, most recently with Diamond Management and Technology Consultants, where he served as President and Chief Operating Officer.
Page 1 of 1 (10 results)
